Biotech Investors & VC Firms in United States

563 firms in this list, with a median first check of $500K. 45 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
HC HCVC AHARJYAF6 people · Leads rounds	88🔒	—		Pre-Seed–Series A	—	+ Add to CRM
20 2048 Ventures AIJWZADC6 people · Leads rounds	88🔒	New York	US	Pre-Seed–Seed	$500K – $3M	+ Add to CRM
AR Arboretum Ventures JGTPDKJT21 people · Leads rounds	88🔒	Milwaukee	US	Pre-Seed–Series A	$5M – $15M	+ Add to CRM
RE Rev1 Ventures DRAOAODG30 people · Leads rounds	88🔒	Columbus	US	Pre-Seed–Series A	—	+ Add to CRM
BI BioGenerator Ventures MSCWJMAM23 people · Leads rounds	88🔒	St. Louis	US	Pre-Seed–Series B	$50K – $250K	+ Add to CRM
BO Boutique Venture Partners DEDRREST19 people	88🔒	Palo Alto	US	Pre-Seed–Series A	—	+ Add to CRM
SA Sanderling Ventures RGFMTMTW9 people	88🔒	San Mateo	US	Seed–Late Stage	$50K – $1M	+ Add to CRM
M M Ventures HGBACPCU11 people	88🔒	Los Angeles	US	Seed–Series A	$10.8M	+ Add to CRM
EX Excelerate Health Ventures BBMMASBB31 people · Leads rounds	88🔒	Research Triangle Park	US	Seed–Series A	—	+ Add to CRM
HA HAWKTAIL	88🔒	San Francisco	US	—	—	+ Add to CRM
WI WI Harper Group CWELPCPW20 people	88🔒	Taipei	TW	Seed–Series C	$5M – $15M	+ Add to CRM
NA National Venture Development ABDV2 people	88🔒	San Francisco	US	Seed–Growth	$2M – $5M	+ Add to CRM
ES Essex Woodlands Healthcare Partners MSBABMEH18 people · Follows rounds	88🔒	New York	US	Growth–Late Stage	$20M – $80M	+ Add to CRM
VE venBio Partners CGRAARRG8 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
GR Green Park & Golf Ventures CHDCCSCE10 people	88🔒	Dallas	US	Seed–Growth	$500K – $2M	+ Add to CRM
CU Cure Ventures MCAJAMDF20 people	88🔒	Boston	US	Seed	—	+ Add to CRM
LA LAV FCJLYS3 people	88🔒	Hong Kong	HK	Seed–Series C	$5M – $15M	+ Add to CRM
FL Flagship Pioneering NAAKCCDC11 people	88🔒	Cambridge	US	Seed–Series A	$500K – $10M	+ Add to CRM
IN In-Q-Tel ABDGDJDM11 people	88🔒	Tysons	US	Seed–Series A	$100K – $2.5M	+ Add to CRM
EP Epidarex Capital ASERKSLG9 people · Leads rounds	88🔒	Bethesda	US	Pre-Seed–Series A	$2.5M – $6.3M	+ Add to CRM
RE Remiges Ventures, Inc. TKTTTIWO21 people	88🔒	Seattle	US	Pre-Seed–Seed	—	+ Add to CRM
TM TMV Logistics MHSDESAK11 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
JA JAZZ Venture Partners AFJFJLJS8 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
S3 S32 BMACACAH17 people	88🔒	Palo Alto	US	Series A–Late Stage	—	+ Add to CRM

HCVC

Pre-Seed–Series A

AHARJYAF6 people

2048 Ventures

New YorkPre-Seed–Seed$500K – $3M

AIJWZADC6 people

Arboretum Ventures

MilwaukeePre-Seed–Series A$5M – $15M

JGTPDKJT21 people

Rev1 Ventures

ColumbusPre-Seed–Series A

DRAOAODG30 people

BioGenerator Ventures

St. LouisPre-Seed–Series B$50K – $250K

MSCWJMAM23 people

Boutique Venture Partners

Palo AltoPre-Seed–Series A

DEDRREST19 people

Sanderling Ventures

San MateoSeed–Late Stage$50K – $1M

RGFMTMTW9 people

M Ventures

Los AngelesSeed–Series A$10.8M

HGBACPCU11 people

Excelerate Health Ventures

Research Triangle ParkSeed–Series A

BBMMASBB31 people

HAWKTAIL

San Francisco

WI Harper Group

TaipeiSeed–Series C$5M – $15M

CWELPCPW20 people

National Venture Development

San FranciscoSeed–Growth$2M – $5M

ABDV2 people

Essex Woodlands Healthcare Partners

New YorkGrowth–Late Stage$20M – $80M

MSBABMEH18 people

venBio Partners

San FranciscoSeed–Late Stage

CGRAARRG8 people

Green Park & Golf Ventures

DallasSeed–Growth$500K – $2M

CHDCCSCE10 people

Cure Ventures

BostonSeed

MCAJAMDF20 people

LAV

Hong KongSeed–Series C$5M – $15M

FCJLYS3 people

Flagship Pioneering

CambridgeSeed–Series A$500K – $10M

NAAKCCDC11 people

In-Q-Tel

TysonsSeed–Series A$100K – $2.5M

ABDGDJDM11 people

Epidarex Capital

BethesdaPre-Seed–Series A$2.5M – $6.3M

ASERKSLG9 people

Remiges Ventures, Inc.

SeattlePre-Seed–Seed

TKTTTIWO21 people

TMV Logistics

New YorkSeed–Series A

MHSDESAK11 people

JAZZ Venture Partners

San FranciscoSeed–Late Stage

AFJFJLJS8 people

S32

Palo AltoSeries A–Late Stage

BMACACAH17 people

Data sourced from public filings and firms' own websites — see our methodology.